{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:54Z","timestamp":1788142914974,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dld.2023.11.021","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T19:56:47Z","timestamp":1701547007000},"page":"964-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease \u2013 A comprehensive narrative review"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-1412","authenticated-orcid":false,"given":"Nicola","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Giuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Mastrorocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santopaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Marcozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bezzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Dal Buono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gabbiadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-1779","authenticated-orcid":false,"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-0118","authenticated-orcid":false,"given":"Alessandro","family":"Armuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dld.2023.11.021_bib0001","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2023.11.021_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2023.11.021_bib0003","article-title":"Unveiling the complexity of porto-sinusoidal vascular disorder in IBD: a call for further investigation [published online ahead of print, 2023 May 30]","author":"Pugliese","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.dld.2023.11.021_bib0004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2023.11.021_bib0006","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension [published correction appears in J Hepatol. 2022 Apr 14;:]","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.11.021_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/HMER.S282674","article-title":"Identifying patients at high risk of developing non-cirrhotic portal hypertension","volume":"13","author":"Gioia","year":"2021","journal-title":"Hepat Med"},{"issue":"7","key":"10.1016\/j.dld.2023.11.021_bib0008","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/liv.15257","article-title":"High prevalence of porto-sinusoidal vascular disease in patients with constantly elevated gamma-glutamyl transferase levels","volume":"42","author":"Pugliese","year":"2022","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.dld.2023.11.021_bib0009","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apt.12490","article-title":"Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy","volume":"38","author":"Musumba","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00365520701800266","article-title":"Histopathology of liver biopsies from a thiopurine-na\u00efve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia","volume":"43","author":"De Boer","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2023.11.021_bib0011","article-title":"Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension [published online ahead of print, 2023 Sep 20]","author":"Gioia","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0012","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.11.021_bib0013","first-page":"162","article-title":"Nodular regenerative hyperplasia: a rare complication of treatment with thiopurines in patients with Crohn's Disease","volume":"4","author":"Testa","year":"2018","journal-title":"J Hepatol Gastroint Dis"},{"issue":"13","key":"10.1016\/j.dld.2023.11.021_bib0014","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4254\/wjh.v9.i13.613","article-title":"Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease","volume":"9","author":"Tran-Minh","year":"2017","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.11.021_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MIB.0000000000000197","article-title":"Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD","volume":"21","author":"Amin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.dld.2023.11.021_bib0017","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/MIB.0b013e318281f28f","article-title":"Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients","volume":"19","author":"Chaparro","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.dld.2023.11.021_bib0018","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ibd.21221","article-title":"Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts","volume":"16","author":"Jharap","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5217\/ir.2020.00016","article-title":"Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn's disease","volume":"19","author":"Seo","year":"2021","journal-title":"Intest Res"},{"issue":"10","key":"10.1016\/j.dld.2023.11.021_bib0020","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/lt.20554","article-title":"Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity","volume":"11","author":"de Boer","year":"2005","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.dld.2023.11.021_bib0021","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.crohns.2012.07.006","article-title":"Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease","volume":"7","author":"Tuyama","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.dld.2023.11.021_bib0022","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.gastrohep.2011.03.023","article-title":"Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease","volume":"34","author":"L\u00f3pez-Mart\u00edn","year":"2011","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0023","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0024","first-page":"342","article-title":"Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature","volume":"76","author":"Dooremont","year":"2013","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/08923973.2010.509727","article-title":"Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease","volume":"33","author":"B\u0142ogowski","year":"2011","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0026","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0399-8320(05)82136-0","article-title":"Azathioprine induced nodular regenerative hyperplasia in IBD patients","volume":"29","author":"Daniel","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"issue":"10","key":"10.1016\/j.dld.2023.11.021_bib0027","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0028","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042737-200605000-00018","article-title":"Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy","volume":"18","author":"Seiderer","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.11.021_bib0029","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gastrohep.2010.10.004","article-title":"Hiperplasia nodular regenerativa: hepatotoxicidad por azatioprina en un paciente con enfermedad de Crohn [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease]","volume":"34","author":"L\u00f3pez-Mart\u00edn","year":"2011","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MIB.0000000000001036","article-title":"Nodular regenerative hyperplasia of the liver in patients with IBD treated with allopurinol-thiopurine combination therapy","volume":"23","author":"Seinen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"18","key":"10.1016\/j.dld.2023.11.021_bib0031","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-2008-1075672","article-title":"Portale Hypertension unter Azathioprin bei Morbus Crohn\u2013ein h\u00e4ufiges Ph\u00e4nomen? [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease\u2013a frequent phenomenon?]","volume":"133","author":"Ehmsen","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.dld.2023.11.021_bib0032","first-page":"675","article-title":"Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease","volume":"151","author":"Cohen-Ezra","year":"2012","journal-title":"Harefuah"},{"issue":"1313","key":"10.1016\/j.dld.2023.11.021_bib0033","first-page":"74","article-title":"Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease","volume":"123","author":"Bryant","year":"2010","journal-title":"N Z Med J"},{"issue":"38","key":"10.1016\/j.dld.2023.11.021_bib0034","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1055\/s-0028-1085573","article-title":"Nodul\u00e4re regenerative Hyperplasie als Nebenwirkung von Azathioprin bei Morbus Crohn [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease]","volume":"133","author":"Schumann","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4321\/S1137-66272013000200022","article-title":"Hepatotoxicidad inducida por azatioprina en paciente con enfermedad de Crohn [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease]","volume":"36","author":"Ruiz-Clavijo","year":"2013","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.dld.2023.11.021_bib0036","first-page":"A1276","article-title":"Niet-cirrotische portale hypertensie: zeldzame oorzaak van hoge gastro-intestinale bloedingen [Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding]","volume":"154","author":"Schouten","year":"2010","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.dld.2023.11.021_bib0037","article-title":"Azathioprine-induced porto-sinusoidal vascular disease complicated with esophageal varices in Crohn's disease patient - Case report [published online ahead of print, 2023 Apr 17]","author":"Yazaki","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2023.11.021_bib0038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.crohns.2010.08.007","article-title":"Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease","volume":"5","author":"Calabrese","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.dld.2023.11.021_bib0039","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s10620-014-3052-3","article-title":"Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease","volume":"59","author":"Pola","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.dld.2023.11.021_bib0040","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00330-006-0544-3","article-title":"Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques","volume":"17","author":"Zech","year":"2007","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0041","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ibd.21330","article-title":"Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine","volume":"17","author":"Seksik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0042","first-page":"79","article-title":"Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease","volume":"108","author":"Su\u00e1rez Ferrer","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.dld.2023.11.021_bib0043","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/MEG.0000000000001980","article-title":"The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients","volume":"33","author":"Gilissen","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"40","key":"10.1016\/j.dld.2023.11.021_bib0044","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3748\/wjg.v22.i40.9012","article-title":"Efficacy of thioguanine treatment in inflammatory bowel disease: a systematic review","volume":"22","author":"Meijer","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/17474124.2017.1294062","article-title":"Is there a role for thioguanine therapy in IBD in 2017 and beyond?","volume":"11","author":"Taylor","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2023.11.021_bib0046","first-page":"1","article-title":"Emerging therapies for the treatment of ulcerative colitis [published online ahead of print, 2020 Mar 9]","author":"Pugliese","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"issue":"11","key":"10.1016\/j.dld.2023.11.021_bib0047","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0048","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2023.11.021_bib0049","doi-asserted-by":"crossref","unstructured":"de Boer N.K., Zondervan P.E., Gilissen L.P., et al. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients. Dig Liver Dis. 2008;40(2):108\u201313. doi:10.1016\/j.dld.2007.10.013","DOI":"10.1016\/j.dld.2007.10.013"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2008.07.314","article-title":"6-Thioguanine therapy in Crohn's disease\u2013observational data in Swedish patients","volume":"41","author":"Almer","year":"2009","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0051","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.11.021_bib0052","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/apt.15280","article-title":"Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies","volume":"50","author":"Simsek","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dld.2023.11.021_bib0053","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1097\/MIB.0000000000000869","article-title":"The prevalence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with thioguanine is not associated with clinically significant liver disease","volume":"22","author":"van Asseldonk","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.dld.2023.11.021_bib0054","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/2050640616663438","article-title":"Thioguanine in inflammatory bowel disease: long-term efficacy and safety","volume":"5","author":"Ward","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/liv.12936","article-title":"Obliterative portal venopathy without portal hypertension: an underestimated condition","volume":"36","author":"Guido","year":"2016","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0056","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12111785","article-title":"Obliterative portal venopathy: findings at CT imaging","volume":"263","author":"Glatard","year":"2012","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.dld.2023.11.021_bib0057","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00261-020-02831-w","article-title":"Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI","volume":"46","author":"Kang","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0058","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2214\/AJR.11.6855","article-title":"Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation","volume":"198","author":"Krishnan","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.dld.2023.11.021_bib0059","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00330-022-09132-4","article-title":"Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder","volume":"33","author":"Lampichler","year":"2023","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.0106-9543.2002.01663.x","article-title":"Heterogeneous hepatic enhancement on CT angiography in idiopathic portal hypertension","volume":"22","author":"Waguri","year":"2002","journal-title":"Liver"},{"issue":"9","key":"10.1016\/j.dld.2023.11.021_bib0061","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jgh3.12795","article-title":"Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis","volume":"6","author":"Ozturk","year":"2022","journal-title":"JGH Open"},{"issue":"3","key":"10.1016\/j.dld.2023.11.021_bib0062","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cgh.2018.05.009","article-title":"Clinical course of nodular regenerative hyperplasia in thiopurine treated inflammatory bowel disease patients","volume":"17","author":"Simsek","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:10:39Z","timestamp":1716617439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865823010393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1590865823010393"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.11.021","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease \u2013 A comprehensive narrative review","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}